HEPION PHARMACEUTICALS, INC. (HEPA) Free cash flow 2016–2023
HEPION PHARMACEUTICALS, INC. (HEPA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$40.9MFY2023 · since FY2016: -$16.6M → -$40.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$40.9M | -16.9% |
| FY2022 | -$35.0M | -11.6% |
| FY2021 | -$31.4M | -92.9% |
| FY2020 | -$16.3M | -113.4% |
| FY2019 | -$7.6M | — |
| FY2017 | -$19.2M | -15.9% |
| FY2016 | -$16.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice